When more isn’t better: the surprising superiority of glycoprotein-only Marburg vaccines

When more isn't better: the surprising superiority of glycoprotein-only Marburg vaccines Marburg virus (MARV) is classified by

Authors

Publication Details

Journal
Journal of Clinical Investigation
Published
2025-09-02
DOI
https://doi.org/10.1172/jci195933
Primary Topic
Viral Infections and Outbreaks Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

When more isn’t better: the surprising superiority of glycoprotein-only Marburg vaccines

Pablo Penaloza‐MacMaster
Journal of Clinical Investigation
Viral Infections and Outbreaks Research
article

When more isn’t better: the surprising superiority of glycoprotein-only Marburg vaccines

Pablo Penaloza‐MacMaster
article en

Abstract

When more isn't better: the surprising superiority of glycoprotein-only Marburg vaccines Marburg virus (MARV) is classified by

Journal of Clinical InvestigationVol. 135(17)
National Institutes of Health, National Institute on Drug Abuse, National Cancer Institute
Openalex Percentile: Top 72%
Viral Infections and Outbreaks Research
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

When more isn’t better: the surprising superiority of glycoprotein-only Marburg vaccines — Pablo Penaloza‐MacMaster · Journal of Clinical Investigation (2025) | TGRS Research Map | TGRS